2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one, 95.0%, 100g

N-(3-Aminopropyl)morpholine>99.0%(GC)25mL

1-(3,4-Dichlorophenyl)cyclopropanecarbonitrile, 95%, 5g

5-Chloro-2,3-diphenylpyrazine, 95.0%, 1g

1-Bromo-2-naphthonitrile, 98+%, 250mg

3-(2,4-Dichlorophenoxymethyl)-4-methoxy-benzaldehyde, 100mg

(2-Bromo-6-fluorophenyl)methanol, 95.0%, 10g

6-Chloro-4-methoxynicotinaldehyde, 97%, 100mg

1-(4-Isopropylphenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 98%, 250mg

4-Bromo-6-(2-methoxyethoxy)isoindolin-1-one, 98%, 250mg

(2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, 97%, 250mg

[(4-methyl-1H-benzimidazol-2-yl)methyl]amine dihydrochloride, 95.0%, 5g

EDTA dipotassium salt dihydrate, min. 99%, for synthesis, 5 kg, plastic packaging.